Introduction to Erdafitinib

Erdafitinib (Erdafitinib) is a new type of targeted therapy drug, mainly used to treat advanced or metastatic urothelial cancer (UC) with fibroblast growth factor receptor (FGFR) gene abnormalities. UC is a cancer of the urinary system, including the bladder, urethra and renal pelvis. Erdafitinib is a small molecule kinase inhibitor that blocks the growth and spread of tumor cells by inhibiting the abnormally activated FGFR signaling pathway, thereby achieving the purpose of treatment.

The uniqueness of this drug is that it is highly selective for FGFR gene abnormalities and can more accurately intervene in the biological processes of tumor cells. Clinical trial data show that erdafitinib shows significant efficacy for patients with UC who have previously been ineffective with other treatments, providing new treatment hope for this patient group.

Erdafitinib is usually an oral medication, and patients can take it according to a specific dose and time under the guidance of a doctor. Before use, doctors usually conduct genetic testing to determine whether the patient has indications, that is, whether there is an abnormality in the FGFR gene. This helps ensure the precise application of drugs and improves the level of individualization of treatment.

However, like all drugs, erdafitinib may also cause some adverse reactions, including but not limited to high blood pressure, hand-foot syndrome, visual problems, etc. Therefore, during use, doctors will closely monitor the patient's physical condition and make appropriate management and adjustments as needed.

Erdafitinib is not currently available in the country, so patients cannot purchase it domestically and need to purchase erdafitinib through foreign channels. The original drug of erdafitinib is mainly the Hong Kong version of the original drug, with a price of more than 20,000, and needs to be purchased through a Hong Kong pharmacy. The generic drugs are relatively cheaper, mainly the Laos version and the Bangladesh Yaopin International version, with a price of about 1,000 to 2,000, and the ingredients of the original drug and the generic drug are basically the same.